Multiple Myeloma: New drug, Revimid looks promising.

Revimid is a thalidomide analog that appears to be more active than Thalidomide but less toxic. Phase II and III trials are now in progress. [P] For further information contact Dana Farber Cancer Center.

Webmaster

August 04, 2003